Topic: COVID-19 vaccine development

The Short Report – April 28, 2021: COVID-19 data portal goes live, Protein Industries Canada launches new phase of plant-based food plan, Carleton funding bolsters ecosystem conservation, and more

Genome Canada’s portal for tracking variants of concern across Canada is up and running; a Carleton biology team gets support for bolstering ecosystem conservation; Protein Industries Canada starts the second phase of plans to boost plant-based foods, feed and ingredients; a briefing from the Royal Society of Canada calls on federal leadership to stabilize the postsecondary sector; and more.

Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics

The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.